Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Using curved and straight fetoscopes for in-utero surgery

Official title: A Prospective Study on the Efficacy of the Karl Storz Curved Fetoscope (11508aak) and Its Straight Version (11506akk) for In-utero Surgery

Run by The University of Texas Health Science Center, Houston · NCT06425471 · Data updated 2026-11-12

This study is testing whether using a curved fetoscope for in-utero surgeries can lead to better outcomes for fetuses and newborns compared to using a straight fetoscope or no fetoscope at all.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment50 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedApril 4, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedAugust 14, 2025
Trial IDNCT06425471 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women who meet the criteria for in-utero surgery based on their specific medical conditions.

Probably not a fit

Patients who may not benefit from this study include those with contraindications to surgery, significant fetal anomalies, or maternal health issues that complicate the procedure.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of the KARL STORZ curved fetoscope and its straight version for performing in-utero surgeries. It will prospectively compare outcomes from patients undergoing these procedures with the fetoscopes to historical control data from patients who had similar surgeries without the use of these instruments. The goal is to determine if the curved fetoscope improves surgical outcomes for fetuses and newborns.

Why it matters

Potential benefit: If successful, this study could enhance the safety and efficacy of in-utero surgeries, potentially improving outcomes for affected fetuses and newborns.

How similar studies have gone: While this approach is innovative, it is based on historical data, and similar studies have not been widely reported, making this a potentially novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant woman
* The patient fulfills the criteria for in-utero surgery based on the standard of care, which is specific for each condition
* Patient of the baby provides signed informed consent that details the maternal and fetal risks involved with the procedure

Exclusion Criteria:

* Contraindication to abdominal surgery, fetoscopic surgery, or general anesthesia
* Allergy or previous adverse reaction to a study medication specified in this protocol
* Preterm labor, preeclampsia, or a uterine anomaly (e.g., large fibroid tumor) that is unavoidable during surgery in the index pregnancy
* Fetal aneuploidy, genomic variants of known significance if an amniocentesis has been performed, other major fetal anomalies or disorders that may impact the fetal/neonatal survival, or a known syndromic mutation
* Suspicion of a major recognized syndrome by ultrasound or MRI
* Maternal BMI \>40 kg/m2
* High risk for fetal hemophilia

Where it's running

  • The University of Texas health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Jimmy Espinoza, MD, MSc,FACOG — The University of Texas Health Science Center, Houston
  • Study coordinator: Jimmy Espinoza, MD, MSc,FACOG
  • Email: Jimmy.Espinoza@uth.tmc.edu
  • Phone: (713) 500-5859

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.